lenalidomide,dexamethasone,bortezomib
takeda
['bet', 'determination', 'mmsm', 'gem-cesar']
congress l #ash22 from discusses findings from the gem-cesar trial for smm. at 70 months, 94% of patients have not progressed to mm, with biochemical progression in 48% of patients #mmsm #myeloma 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma